四川宏明博思药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
23
NMPA:23
Drug Approvals
Pantoprazole Sodium for Injection
- Product Name
- 注射用泮托拉唑钠
- Approval Number
- 国药准字H20143129
- Approval Date
- Feb 6, 2024
NMPA
Pantoprazole Sodium for Injection
- Product Name
- 注射用泮托拉唑钠
- Approval Number
- 国药准字H20143128
- Approval Date
- Feb 6, 2024
NMPA
Azithromycin for Injection
- Product Name
- 注射用阿奇霉素
- Approval Number
- 国药准字H20093666
- Approval Date
- Jan 10, 2024
NMPA
Clindamycin Phosphate for Injection
- Product Name
- 注射用克林霉素磷酸酯
- Approval Number
- 国药准字H20093563
- Approval Date
- Jan 10, 2024
NMPA
Azithromycin for Injection
- Product Name
- 注射用阿奇霉素
- Approval Number
- 国药准字H20093667
- Approval Date
- Jan 10, 2024
NMPA
Clindamycin Phosphate for Injection
- Product Name
- 注射用克林霉素磷酸酯
- Approval Number
- 国药准字H20093564
- Approval Date
- Jan 10, 2024
NMPA
Dimethyl Fumarate Enteric Capsules
- Product Name
- 富马酸二甲酯肠溶胶囊
- Approval Number
- 国药准字H20233993
- Approval Date
- Dec 27, 2023
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found